Conor McNamara
Stock Analyst at RBC Capital
(0.94)
# 3,871
Out of 4,996 analysts
137
Total ratings
25.74%
Success rate
-17.11%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $51.84 | +40.82% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $2.82 | +77.30% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $162.97 | +56.47% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.61 | +86.34% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $53.57 | -14.13% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $67.21 | +29.45% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $11.84 | +43.58% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $91.69 | +37.42% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $271.36 | +50.72% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $269.90 | +51.54% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $125.61 | +62.41% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $464.24 | +37.21% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $184.84 | +35.25% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $28.33 | +115.32% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.13 | +69.49% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $51.84
Upside: +40.82%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $2.82
Upside: +77.30%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $162.97
Upside: +56.47%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.61
Upside: +86.34%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $53.57
Upside: -14.13%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $67.21
Upside: +29.45%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $11.84
Upside: +43.58%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $91.69
Upside: +37.42%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $271.36
Upside: +50.72%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $269.90
Upside: +51.54%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $125.61
Upside: +62.41%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $464.24
Upside: +37.21%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $184.84
Upside: +35.25%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $28.33
Upside: +115.32%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.13
Upside: +69.49%